Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7074944 | 0.98 | CYP3A4 (0.41) | POLBMEN1APOBEC3APMP22KMT2A | |
| Hydrochloric Acid SCHEMBL8022255 | 0.96 | CYP3A4 (0.39) | POLBMEN1APOBEC3APMP22KMT2A | |
| SCHEMBL5281905 | 0.75 | APOBEC3A (0.37) | POLBMEN1APOBEC3APMP22KMT2A | |
| SCHEMBL5944513 | 0.73 | APOBEC3A (0.40) | POLBMEN1APOBEC3APMP22KMT2A | |
| SCHEMBL13223522 | 0.71 | SIRT6 (0.54) | POLBMEN1KMT2AMAPK1HSD17B10 | |
| Acetamide SCHEMBL18425023 | 0.70 | MAPT (0.40) | POLBKMT2AHSD17B10HRH4 | |
| SCHEMBL15293601 | 0.70 | CYP1A2 (0.43) | POLBMEN1APOBEC3APMP22KMT2A | |
| SCHEMBL11163692 | 0.69 | HPGDS (0.34) | POLBMEN1APOBEC3APMP22KMT2A | |
| Acetamide SCHEMBL9275850 | 0.68 | HSD17B10 (0.39) | POLBMEN1KMT2AHSD17B10MC4R | |
| Iodide SCHEMBL10537687 | 0.68 | CYP2D6 (0.39) | POLBMEN1APOBEC3APMP22KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831772-A2 | INTRAURETHRAL PHARMACOTHERAPY OF INCONTINENCE | IOTEK, INC. (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1996040054-A2 | INTRAURETHRAL PHARMACOTHERAPY OF INCONTINENCE | IOTEK, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-2016149454-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2016-09-22 | — | — | WO | disclosed |
| WO-2014106007-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | WO | disclosed |
| EP-2160195-A1 | NOVEL MUSCLE RELAXANT USING NEGATIVE CHARGE GOLD NANOPARTICLE WITH CHOLINE | Chin, Chur (KR) | 2010-03-10 | — | — | EP | disclosed |
| WO-2009001994-A1 | NOVEL MUSCLE RELAXANT USING NEGATIVE CHARGE GOLD NANOPARTICLE WITH CHOLINE | CHIN CHUR (KR) | 2008-12-31 | — | — | WO | disclosed |
| WO-2001058436-A1 | ANTAGONISTS FOR NICOTINIC ACETYLCHOLINE RECEPTOR, WHICH ARE CONTAINING BORNEOL OR CAMPHOR AS AN ACTIVE INGREDIENT | GENOMINE, INC. (KR) | 2001-08-16 | — | — | WO | disclosed |
| WO-2000017207-A1 | 3,4-DIHYDRO -N-[[1-(3 -HYDROXYBUTYL) -4-PIPERIDINYL] METHYL] -2H-[1,3] OXAZINO[3, 2-A]INDOLE -10-CARBOXAMIDE AS 5-HT(4) RECEPTOR ANTAGONIST | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-03-30 | — | — | WO | disclosed |
| EP-0486621-A4 | NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY | — | 1993-03-31 | — | — | EP | disclosed |
| EP-0486621-A1 | NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY | The Children's Medical Center Corporation (US) | 1992-05-27 | — | — | EP | disclosed |
| WO-1991002810-A1 | NMDA OXIDIZING AGENTS FOR PROTECTING NEURONS FROM INJURY | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1991-03-07 | — | — | WO | disclosed |